Dear Francois, Intekhab

the correct reference for the Sc statistic is

Lawrence, M. C. & Colman, P. M. (1993). Shape complementarity at
protein/protein interfaces. J. Mol. Biol. 234, 946-950.

You can also find a description in the March 2001 CCP4 newsletter (#39).

I am not certain why you cannot find it within the Windows version - it
should simply be called "SC".

sincerely

Mike

Mike Lawrence, PhD

Associate Professor and WEHI Fellow
Division of Structural Biology
Walter and Eliza Hall Institute of Medical Research
1G Royal Parade, Parkville
Victoria 3052, AUSTRALIA

Tel. 61-3-9345-2693
Fax 61-3-9345-2686
Email: lawre...@wehi.edu.au







> Hi,
>
> This is the first time I read about "shape complementarity statistics".
>
> According to:
> "A structural basis for the activity of retro-Diels–Alder catalytic
> antibodies: Evidence for a catalytic aromatic residue"
>
> As seen here:
> http://www.pnas.org/content/99/15/9674.full
>
> ---
> [...] compute the SHAPE COMPLEMENTARITY STATISTICS index (Sc). This
> statistics index measures the geometric surface complementarity via the
> use of normal products, and the extent to which the interacting surface
> elements are brought into proximity via an exponential distance
> separation term. Sc values usually range from 0.70 to 0.76 for
> proteinase–protein inhibitor surfaces, from 0.64 to 0.68 for
> antigen–antibody complexes, and from 0.45 to 0.70 for MHC–peptide
> complexes (30).
> ---
>
> I am frightened. :(
> I don't think this is in my book "The cartoon guide
> to statistics". Despite the book is really nice.
>
> Regards,
> F.
>
> intekhab alam wrote:
>> I want to calculate the shape comlementarity statitics (SC) of a dimeric
>> protein using CCp4. I am using CCP4 6.1.3 on windows but the SC program
>> is not available in that suite.
>> Which version of CCP4 has that program. Are there any other programs
>> that can calculate that.
>>
>> Thanks
>>
>> --
>> INTEKHAB ALAM
>> LABORATORY OF STRUCTURAL BIOINFORMATICS
>> KOREA UNIVERSITY, SEOUL
>



______________________________________________________________________
The information in this email is confidential and intended solely for the 
addressee.
You must not disclose, forward, print or use it without the permission of the 
sender.
______________________________________________________________________

Reply via email to